Approval · Notice of Compliance 12507 · 2011
LEUKINE: Notice of Compliance 12507
Issued July 29, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12507
- Date
- July 29, 2011
- Company
- Genzyme Canada Inc
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Hematopoietic Growth Factor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEUKINE | 02369893 | — |
| LEUKINE | 02369907 | — |
Medicinal ingredients
- SARGRAMOSTIM 250 MCG per VIAL
- SARGRAMOSTIM 500 MCG per VIAL